Aru B, Pehlivanoğlu C, Dal Z, Dereli-Çalışkan NN, Gürlü E, Yanıkkaya-Demirel G. A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia. Front Immunol 2023;14:1108200. [PMID: 36742324 DOI: 10.3389/fimmu.2023.1108200][Reference Citation Analysis]
2
Hossain SM, Gimenez G, Stockwell PA, Tsai P, Print CG, Rys J, Cybulska-stopa B, Ratajska M, Harazin-lechowska A, Almomani S, Jackson C, Chatterjee A, Eccles MR. Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures. Front Immunol 2022;13:955063. [DOI: 10.3389/fimmu.2022.955063][Reference Citation Analysis]
3
Palaniappan A, Sarathi A. A comprehensive algorithmic dissection yields biomarker discovery and insights into the discrete stage-wise progression of colorectal cancer.. [DOI: 10.1101/2022.08.16.22278877][Reference Citation Analysis]
